KEYWORDS: Tumors, Breast, Digital breast tomosynthesis, Biomedical optics, Mammography, Tissues, Hemodynamics, Chemotherapy, Breast cancer, Magnetic resonance imaging
SignificanceAchieving pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) is a significant predictor of increased likelihood of survival in breast cancer patients. Early prediction of pCR is of high clinical value as it could allow personalized adjustment of treatment regimens in non-responding patients for improved outcomes.AimWe aim to assess the association between hemoglobin-based functional imaging biomarkers derived from diffuse optical tomography (DOT) and the pathological outcome represented by pCR at different timepoints along the course of NACT.ApproachTwenty-two breast cancer patients undergoing NACT were enrolled in a multimodal DOT and X-ray digital breast tomosynthesis (DBT) imaging study in which their breasts were imaged at different compression levels. Logistic regressions were used to study the associations between DOT-derived imaging markers evaluated after the first and second cycles of chemotherapy, respectively, with pCR status determined after the conclusion of NACT at the time of surgery. Receiver operating characteristic curve analysis was also used to explore the predictive performance of selected DOT-derived markers.ResultsNormalized tumor HbT under half compression was significantly lower in the pCR group compared to the non-pCR group after two chemotherapy cycles (p=0.042). In addition, the change in normalized tumor StO2 upon reducing compression from full to half mammographic force was identified as another potential indicator of pCR at an earlier time point, i.e., after the first chemo cycle (p=0.038). Exploratory predictive assessments showed that AUCs using DOT-derived functional imaging markers as predictors reach as high as 0.75 and 0.71, respectively, after the first and second chemo cycle, compared to AUCs of 0.50 and 0.53 using changes in tumor size measured on DBT and MRI.ConclusionsThese findings suggest that breast DOT could be used to assist response assessment in women undergoing NACT, a critical but unmet clinical need, and potentially enable personalized adjustments of treatment regimens.
Transcatheter aortic valve replacement (TAVR) surgery has a risk of cognitive impairment and neurological injury. Currently, there are few options for non-invasively monitoring brain activity and perfusion, with electroencephalography, transcranial Doppler, and near-infrared spectroscopy (NIRS) all having significant drawbacks. By combining NIRS with diffuse correlation spectroscopy (DCS) we can obtain a more complete picture of cerebral hemodynamics during TAVR procedures and examine the link to neurological outcomes. We show examples of post-valve replacement hemodynamic changes that correspond with worse/better patient outcomes
Multimodal x-ray mammography and optical imaging data were acquired on six breast cancer patients who underwent neoadjuvant chemotherapy (NACT) but reponded differently to their treatment. Changes in tumor contrast quantified by total hemoglobin concentration (HbT) between baseline and pre-cycle 3 are distinctive across various levels of pathological outcomes. While decreases in lesion size have been observed in all cases regardless of pathological outcomes, optical contrast shows more distinctive response characteristics that could potentially be used to differentiate complete responders from partial responders.
Breast cancer is a highly heterogeneous disease comprising a variety of genotypes and phenotypes of varying levels of aggressiveness. This presents significant challenges to clinical management of early-stage cancers. In this paper, we describe the use of multimodal optical technologies including near-infrared (NIR) spectroscopy, diffuse correlation spectroscopy (DCS) and indocyanine green (ICG) fluorescence imaging to evaluate the aggressiveness and progression of two patient-derived xenograft models of human breast cancer. Optical markers reveal distinctive features between low- and high-aggressiveness tumors that could potentially be translated for clinical use.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.